General Information of Drug Off-Target (DOT) (ID: OT78HUZB)

DOT Name Deoxyguanosine kinase, mitochondrial (DGUOK)
Synonyms EC 2.7.1.113; Deoxyadenosine kinase, mitochondrial; EC 2.7.1.76
Gene Name DGUOK
Related Disease
Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) ( )
Acute liver failure ( )
Acute monocytic leukemia ( )
Acute myelogenous leukaemia ( )
Advanced cancer ( )
Childhood acute lymphoblastic leukemia ( )
Cholestasis ( )
Colon cancer ( )
Colon carcinoma ( )
Colorectal carcinoma ( )
Cystathioninuria ( )
Hepatic encephalopathy ( )
Inflammatory bowel disease ( )
Liver cirrhosis ( )
Lung adenocarcinoma ( )
Mitochondrial disease ( )
Mitochondrial DNA depletion syndrome 4a ( )
Mitochondrial DNA depletion syndrome, hepatocerebral form ( )
Myopathy ( )
Neoplasm ( )
Portal hypertension, noncirrhotic ( )
Liver failure ( )
Melanoma ( )
Mitochondrial DNA depletion syndrome ( )
Progressive external ophthalmoplegia ( )
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4 ( )
Asthma ( )
Obsolete portal hypertension, noncirrhotic ( )
UniProt ID
DGUOK_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
2OCP
EC Number
2.7.1.113; 2.7.1.76
Pfam ID
PF01712
Sequence
MAAGRLFLSRLRAPFSSMAKSPLEGVSSSRGLHAGRGPRRLSIEGNIAVGKSTFVKLLTK
TYPEWHVATEPVATWQNIQAAGTQKACTAQSLGNLLDMMYREPARWSYTFQTFSFLSRLK
VQLEPFPEKLLQARKPVQIFERSVYSDRYIFAKNLFENGSLSDIEWHIYQDWHSFLLWEF
ASRITLHGFIYLQASPQVCLKRLYQRAREEEKGIELAYLEQLHGQHEAWLIHKTTKLHFE
ALMNIPVLVLDVNDDFSEEVTKQEDLMREVNTFVKNL
Function
Phosphorylates deoxyguanosine and deoxyadenosine in the mitochondrial matrix, with the highest efficiency for deoxyguanosine. In non-replicating cells, where cytosolic dNTP synthesis is down-regulated, mtDNA synthesis depends solely on DGUOK and TK2. Phosphorylates certain nucleoside analogs. Widely used as target of antiviral and chemotherapeutic agents.
Tissue Specificity Ubiquitous. Highest expression in muscle, brain, liver and lymphoid tissues.
KEGG Pathway
Purine metabolism (hsa00230 )
Metabolic pathways (hsa01100 )
Nucleotide metabolism (hsa01232 )
Reactome Pathway
Purine salvage (R-HSA-74217 )
BioCyc Pathway
MetaCyc:HS03819-MONOMER

Molecular Interaction Atlas (MIA) of This DOT

28 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) DISKE17B Definitive Autosomal recessive [1]
Acute liver failure DIS5EZKX Strong Biomarker [2]
Acute monocytic leukemia DIS28NEL Strong Altered Expression [3]
Acute myelogenous leukaemia DISCSPTN Strong Altered Expression [3]
Advanced cancer DISAT1Z9 Strong Biomarker [4]
Childhood acute lymphoblastic leukemia DISJ5D6U Strong Altered Expression [3]
Cholestasis DISDJJWE Strong Genetic Variation [5]
Colon cancer DISVC52G Strong Biomarker [6]
Colon carcinoma DISJYKUO Strong Biomarker [6]
Colorectal carcinoma DIS5PYL0 Strong Posttranslational Modification [7]
Cystathioninuria DISOUZ3T Strong Genetic Variation [8]
Hepatic encephalopathy DISEAKAN Strong Biomarker [9]
Inflammatory bowel disease DISGN23E Strong Biomarker [10]
Liver cirrhosis DIS4G1GX Strong Genetic Variation [11]
Lung adenocarcinoma DISD51WR Strong Biomarker [12]
Mitochondrial disease DISKAHA3 Strong Biomarker [13]
Mitochondrial DNA depletion syndrome 4a DISU4RVU Strong Genetic Variation [14]
Mitochondrial DNA depletion syndrome, hepatocerebral form DISXOJLH Strong Biomarker [15]
Myopathy DISOWG27 Strong Genetic Variation [16]
Neoplasm DISZKGEW Strong Biomarker [12]
Portal hypertension, noncirrhotic DISZZMLV Strong Biomarker [17]
Liver failure DISLGEL6 moderate Biomarker [15]
Melanoma DIS1RRCY moderate Altered Expression [18]
Mitochondrial DNA depletion syndrome DISIGZSM moderate Genetic Variation [19]
Progressive external ophthalmoplegia DISX4ATI moderate Genetic Variation [20]
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4 DISANCL5 Supportive Autosomal recessive [21]
Asthma DISW9QNS Disputed Biomarker [22]
Obsolete portal hypertension, noncirrhotic DISC97P7 Limited Autosomal recessive [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 28 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
6 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the expression of Deoxyguanosine kinase, mitochondrial (DGUOK). [23]
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Deoxyguanosine kinase, mitochondrial (DGUOK). [24]
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Deoxyguanosine kinase, mitochondrial (DGUOK). [25]
Testosterone DM7HUNW Approved Testosterone decreases the expression of Deoxyguanosine kinase, mitochondrial (DGUOK). [26]
Genistein DM0JETC Phase 2/3 Genistein decreases the expression of Deoxyguanosine kinase, mitochondrial (DGUOK). [27]
Milchsaure DM462BT Investigative Milchsaure decreases the expression of Deoxyguanosine kinase, mitochondrial (DGUOK). [29]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of Deoxyguanosine kinase, mitochondrial (DGUOK). [28]
------------------------------------------------------------------------------------

References

1 Classification of Genes: Standardized Clinical Validity Assessment of Gene-Disease Associations Aids Diagnostic Exome Analysis and Reclassifications. Hum Mutat. 2017 May;38(5):600-608. doi: 10.1002/humu.23183. Epub 2017 Feb 13.
2 Deep Sequencing Reveals Novel Genetic Variants in Children with Acute Liver Failure and Tissue Evidence of Impaired Energy Metabolism.PLoS One. 2016 Aug 2;11(8):e0156738. doi: 10.1371/journal.pone.0156738. eCollection 2016.
3 Real-time quantitative PCR assays for deoxycytidine kinase, deoxyguanosine kinase and 5'-nucleotidase mRNA measurement in cell lines and in patients with leukemia.Leukemia. 2002 Mar;16(3):386-92. doi: 10.1038/sj.leu.2402388.
4 Molecular Pathways: Targeting Diacylglycerol Kinase Alpha in Cancer.Clin Cancer Res. 2015 Nov 15;21(22):5008-12. doi: 10.1158/1078-0432.CCR-15-0413. Epub 2015 Sep 29.
5 Clinical and molecular characteristics of mitochondrial DNA depletion syndrome associated with neonatal cholestasis and liver failure.J Pediatr. 2014 Mar;164(3):553-9.e1-2. doi: 10.1016/j.jpeds.2013.10.082. Epub 2013 Dec 8.
6 Apoptotic Activity of Lactobacillus plantarum DGK-17-Fermented Soybean Seed Extract in Human Colon Cancer Cells via ROS-JNK Signaling Pathway.J Food Sci. 2017 Jun;82(6):1475-1483. doi: 10.1111/1750-3841.13732. Epub 2017 May 10.
7 Epigenetic silencing of diacylglycerol kinase gamma in colorectal cancer.Mol Carcinog. 2017 Jul;56(7):1743-1752. doi: 10.1002/mc.22631. Epub 2017 Mar 6.
8 Novel mutation in DGUOK in hepatocerebral mitochondrial DNA depletion syndrome associated with cystathioninuria.Am J Med Genet A. 2005 Jun 15;135(3):289-91. doi: 10.1002/ajmg.a.30748.
9 Deoxyguanosine kinase deficiency: a report of four patients.J Pediatr Endocrinol Metab. 2017 May 24;30(6):697-702. doi: 10.1515/jpem-2016-0268.
10 Clinical Course of Nodular Regenerative Hyperplasia in Thiopurine Treated Inflammatory Bowel Disease Patients.Clin Gastroenterol Hepatol. 2019 Feb;17(3):568-570. doi: 10.1016/j.cgh.2018.05.009. Epub 2018 Jun 1.
11 Hepato-cerebral syndrome: genetic and pathological studies in an infant with a dGK mutation.Acta Neuropathol. 2004 Aug;108(2):168-71. doi: 10.1007/s00401-004-0872-9. Epub 2004 May 19.
12 The mitochondrial deoxyguanosine kinase is required for cancer cell stemness in lung adenocarcinoma.EMBO Mol Med. 2019 Dec;11(12):e10849. doi: 10.15252/emmm.201910849. Epub 2019 Oct 21.
13 Recessive deoxyguanosine kinase deficiency causes juvenile onset mitochondrial myopathy.Mol Genet Metab. 2012 Sep;107(1-2):92-4. doi: 10.1016/j.ymgme.2012.04.019. Epub 2012 Apr 26.
14 Mitochondrial DNA depletion is a prevalent cause of multiple respiratory chain deficiency in childhood.J Pediatr. 2007 May;150(5):531-4, 534.e1-6. doi: 10.1016/j.jpeds.2007.01.044.
15 A Screen Using iPSC-Derived Hepatocytes Reveals NAD(+) as a Potential Treatment for mtDNA Depletion Syndrome.Cell Rep. 2018 Nov 6;25(6):1469-1484.e5. doi: 10.1016/j.celrep.2018.10.036.
16 Depletion of the other genome-mitochondrial DNA depletion syndromes in humans.J Mol Med (Berl). 2002 Jul;80(7):389-96. doi: 10.1007/s00109-002-0343-5. Epub 2002 May 24.
17 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
18 Nucleoside Analog Activity in Malignant Melanoma Cell Lines.Nucleosides Nucleotides Nucleic Acids. 2015;34(9):639-49. doi: 10.1080/15257770.2015.1047029.
19 A fatal case of mitochondrial DNA depletion syndrome with novel compound heterozygous variants in the deoxyguanosine kinase gene.Oncotarget. 2017 Sep 15;8(48):84309-84319. doi: 10.18632/oncotarget.20905. eCollection 2017 Oct 13.
20 Alteration of nucleotide metabolism: a new mechanism for mitochondrial disorders.Clin Chem Lab Med. 2003 Jul;41(7):845-51. doi: 10.1515/CCLM.2003.128.
21 Next-generation sequencing reveals DGUOK mutations in adult patients with mitochondrial DNA multiple deletions. Brain. 2012 Nov;135(Pt 11):3404-15. doi: 10.1093/brain/aws258. Epub 2012 Oct 4.
22 Diacylglycerol kinase promotes allergic airway inflammation and airway hyperresponsiveness through distinct mechanisms.Sci Signal. 2019 Sep 3;12(597):eaax3332. doi: 10.1126/scisignal.aax3332.
23 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
24 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
25 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
26 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
27 A high concentration of genistein down-regulates activin A, Smad3 and other TGF-beta pathway genes in human uterine leiomyoma cells. Exp Mol Med. 2012 Apr 30;44(4):281-92.
28 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
29 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.